PC
RGNX icon

Pier Capital’s Regenxbio RGNX Stock Holding History

Pier Capital’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-94,433
Closed -$3.48M – 121
2020
Q2 		$3.48M Sell
94,433
-14,050
-13% -$524K 0.56% 95
2020
Q1 		$3.51M Buy
108,483
+19,519
+22% +$813K 0.78% 64
2019
Q4 		$3.65M Sell
88,964
-29,091
-25% -$1.15M 0.6% 86
2019
Q3 		$4.2M Buy
118,055
+9,637
+9% +$390K 0.71% 78
2019
Q2 		$5.57M Sell
108,418
-22,840
-17% -$1.14M 0.86% 72
2019
Q1 		$7.52M Buy
131,258
+66,993
+104% +$3.32M 1.17% 32
2018
Q4 		$2.7M Sell
64,265
-30,227
-32% -$1.77M 0.54% 94
2018
Q3 		$7.13M Sell
94,492
-22,321
-19% -$1.61M 0.9% 75
2018
Q2 		$8.38M Buy
+116,813
New +$5.58M 1.15% 18

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Pier Capital's RGNX Position: Q3 2020 in Review

Pier Capital sold out of Regenxbio (RGNX) in Q3 2020, closing a stake of 94,433 shares — an estimated $3.48M sold.

Pier Capital first reported a position in RGNX in Q2 2018 and held it in 9 quarters. The position peaked at $8.38M in Q2 2018. 166 funds tracked by Wall St. Rank hold RGNX as of Q3 2020.

  • Pier Capital reported no remaining Regenxbio position as of Q3 2020 after selling out during the quarter.
  • Pier Capital sold 94,433 Regenxbio shares in Q3 2020, an estimated $3.48M.
  • Pier Capital first reported a position in Regenxbio in Q2 2018 and held it in 9 quarters.
  • Pier Capital's Regenxbio position peaked at $8.38M in Q2 2018.
  • 166 funds tracked by Wall St. Rank held Regenxbio as of Q3 2020.

Based on Pier Capital's 13F filing for Q3 2020, filed 13 Nov 2020.